BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26329919)

  • 1. Prediction of mutagenicity and carcinogenicity using in silico modelling: A case study of polychlorinated biphenyls.
    Vračko M; Bobst S
    SAR QSAR Environ Res; 2015; 26(7-9):667-82. PubMed ID: 26329919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive models for carcinogenicity and mutagenicity: frameworks, state-of-the-art, and perspectives.
    Benfenati E; Benigni R; Demarini DM; Helma C; Kirkland D; Martin TM; Mazzatorta P; Ouédraogo-Arras G; Richard AM; Schilter B; Schoonen WG; Snyder RD; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2009 Apr; 27(2):57-90. PubMed ID: 19412856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the health effects of polychlorinated biphenyls (PCBs) and their metabolites using quantitative structure-activity relationship (QSAR).
    Ruiz P; Faroon O; Moudgal CJ; Hansen H; De Rosa CT; Mumtaz M
    Toxicol Lett; 2008 Sep; 181(1):53-65. PubMed ID: 18662755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of in silico models for prediction of mutagenicity.
    Bakhtyari NG; Raitano G; Benfenati E; Martin T; Young D
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2013; 31(1):45-66. PubMed ID: 23534394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prioritization of mycotoxins based on mutagenicity and carcinogenicity evaluation using combined in silico QSAR methods.
    Lemée P; Fessard V; Habauzit D
    Environ Pollut; 2023 Apr; 323():121284. PubMed ID: 36804886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of mutagenicity, carcinogenicity, developmental toxicity, and skin sensitisation with Caesar program for a set of conazoles.
    Bolčič-Tavčar M; Vračko M
    Arh Hig Rada Toksikol; 2012 Sep; 63(3):283-92. PubMed ID: 23152378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic QSAR of aromatic amines: new models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens.
    Benigni R; Bossa C; Netzeva T; Rodomonte A; Tsakovska I
    Environ Mol Mutagen; 2007 Dec; 48(9):754-71. PubMed ID: 18008355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinogenicity of the aromatic amines: from structure-activity relationships to mechanisms of action and risk assessment.
    Benigni R; Passerini L
    Mutat Res; 2002 Jul; 511(3):191-206. PubMed ID: 12088717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-activity relationship modelling of the carcinogenic risk of nitroso compounds using regression analysis and the TOPS-MODE approach.
    Helguera AM; Pérez-Machado G; Cordeiro MN; Combes RD
    SAR QSAR Environ Res; 2010 Apr; 21(3-4):277-304. PubMed ID: 20544552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Prediction of Chemically Induced Mutagenicity: How to Use QSAR Models and Interpret Their Results.
    Mombelli E; Raitano G; Benfenati E
    Methods Mol Biol; 2016; 1425():87-105. PubMed ID: 27311463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSARS of mutagens and carcinogens: two case studies illustrating problems in the construction of models for noncongeneric chemicals.
    Benigni R; Richard AM
    Mutat Res; 1996 Nov; 371(1-2):29-46. PubMed ID: 8950348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polychlorinated biphenyls (PCBs): mutagenicity and carcinogenicity.
    Safe S
    Mutat Res; 1989 Jan; 220(1):31-47. PubMed ID: 2492077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of mechanistic data in the IARC evaluations of the carcinogenicity of polychlorinated biphenyls and related compounds.
    Lauby-Secretan B; Loomis D; Baan R; El Ghissassi F; Bouvard V; Benbrahim-Tallaa L; Guha N; Grosse Y; Straif K
    Environ Sci Pollut Res Int; 2016 Feb; 23(3):2220-9. PubMed ID: 26077316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR screening of 70,983 REACH substances for genotoxic carcinogenicity, mutagenicity and developmental toxicity in the ChemScreen project.
    Wedebye EB; Dybdahl M; Nikolov NG; Jónsdóttir SÓ; Niemelä JR
    Reprod Toxicol; 2015 Aug; 55():64-72. PubMed ID: 25797653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International Commission for Protection Against Environmental Mutagens and Carcinogens. Use of SAR in computer-assisted prediction of carcinogenicity and mutagenicity of chemicals by the TOPKAT program.
    Enslein K; Gombar VK; Blake BW
    Mutat Res; 1994 Feb; 305(1):47-61. PubMed ID: 7508547
    [No Abstract]   [Full Text] [Related]  

  • 17. Merging applicability domains for in silico assessment of chemical mutagenicity.
    Liu R; Wallqvist A
    J Chem Inf Model; 2014 Mar; 54(3):793-800. PubMed ID: 24494696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship studies of chemical mutagens and carcinogens: mechanistic investigations and prediction approaches.
    Benigni R
    Chem Rev; 2005 May; 105(5):1767-800. PubMed ID: 15884789
    [No Abstract]   [Full Text] [Related]  

  • 19. Improved in silico prediction of carcinogenic potency (TD50) and the risk specific dose (RSD) adjusted Threshold of Toxicological Concern (TTC) for genotoxic chemicals and pharmaceutical impurities.
    Contrera JF
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):133-41. PubMed ID: 20933038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated approach to assess the domain of applicability of some commercial (Q)SAR models.
    Kulkarni SA; Zhu J
    SAR QSAR Environ Res; 2008; 19(1-2):39-54. PubMed ID: 18311633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.